First Person, which is developing functional mushroom-based cognitive supplements, withdrew its plans for an initial public offering on Thursday. It had filed to raise $13 million by offering 2.9 million shares at a price range of $4 to $5.
The Calgary, Canada-based company was founded in 2021 and booked $7 million in revenue for the 12 months ended June 30, 2023. It had planned to list on the Nasdaq under the symbol FP. EF Hutton was set to be the sole bookrunner on the deal.
